M. Ghashghaei

Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis.

T. Muanza, T. Niazi, M. Kucharczyk, 2019, Current oncology.

Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen‐sensitive prostate cancer cells

M. Paliouras, T. Muanza, M. Trifiro, 2018, The Prostate.

Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells

C. Greenwood, M. Basik, T. Muanza, 2019, Scientific Reports.

miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cells

A. Rouhi, M. Yue, Tuan-Anh Nguyen, 2022, Blood advances.

Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells

C. Greenwood, M. Basik, T. Muanza, 2019, Scientific Reports.